Proteomics

Dataset Information

0

Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant ChemotherapyIdentification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy

ABSTRACT: Neoadjuvant chemotherapy (NAC) has been of recent interest as an alternative to upfront surgery followed by adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma (PDAC). However, a subset of patients does not respond to NAC and may have been better managed by upfront surgery. Hence, there is an unmet need for accurate biomarkers for predicting NAC response in PDAC. This project aimed to identify upregulated proteins in tumor tissue from poor- and good-NAC responders.

INSTRUMENT(S): TripleTOF 6600

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Pancreatic Ductal Cell, Pancreas

DISEASE(S): Pancreatic Ductal Carcinoma

SUBMITTER: Sumit Sahni  

LAB HEAD: Anubhav Mittal

PROVIDER: PXD017051 | Pride | 2020-04-16

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
NP_PCPNET_HighpH.group Other
T001.wiff Wiff
T001.wiff.scan Wiff
T021.wiff Wiff
T021.wiff.scan Wiff
Items per page:
1 - 5 of 73
altmetric image

Publications

Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy.

Sahni Sumit S   Nahm Christopher C   Krisp Christoph C   Molloy Mark P MP   Mehta Shreya S   Maloney Sarah S   Itchins Malinda M   Pavlakis Nick N   Clarke Stephen S   Chan David D   Gill Anthony J AJ   Howell Viive M VM   Samra Jaswinder J   Mittal Anubhav A  

Frontiers in oncology 20200304

<b>Background:</b> Neoadjuvant chemotherapy (NAC) has been of recent interest as an alternative to upfront surgery followed by adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma (PDAC). However, a subset of patients does not respond to NAC and may have been better managed by upfront surgery. Hence, there is an unmet need for accurate biomarkers for predicting NAC response in PDAC. We aimed to identify upregulated proteins in tumor tissue from poor- and good-NAC responders. <  ...[more]

Similar Datasets

Transcriptomics A novel signature of twelve-gene to evaluate neoadjuvant chemotherapy response and predict prognosis in breast cancer
2022-10-11 | GSE197931 | GEO
Transcriptomics Association of immune related expression profile with sensitivity to neoadjuvant chemotherapy using docetaxel, cisplatin and 5-fluorouracil in esophageal squamous cell carcinoma.
2023-11-15 | GSE225178 | GEO
Metabolomics Increased glucose availability sensitizes pancreatic cancer to chemotherapy
2022-10-18 | MTBLS6000 | MetaboLights
Genomic Neoadjuvant Chemotherapy +/- Bevacizumab Pharmacogenomics
| phs001365 | dbGaP
Transcriptomics Response to Neoadjuvant Chemotherapy in Triple Negative Breast tumors.
2016-03-24 | E-GEOD-43816 | biostudies-arrayexpress
Transcriptomics Patient-derived organoids after neoadjuvant FOLFIRINOX predict therapy resistance in pancreatic ductal adenocarcinoma
2021-03-23 | GSE169321 | GEO
Methylation profiling Epigenome analysis of pre- and post-neoadjuvant chemotherapy breast tumor samples
2019-01-31 | GSE106360 | GEO
Other Immune-related gene expression profiling of Epithelial Ovarian Cancer after Neoadjuvant chemotherapy
2022-01-27 | GSE181597 | GEO
Transcriptomics Spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment
2022-05-12 | GSE199102 | GEO
Methylation profiling Identification of DNA methylation biomarkers for prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer [EPIC Array]
2021-12-17 | GSE184159 | GEO